and 25%
glycerol.
Molecular mass: ∼63 kDa
Purity: 70–95% (SDS-PAGE, see Figure 1)
Specific Activity: 667–903 nmole/min/mg (see Figure 2)
Precautions and Disclaimer
This product is for R&D use
, The natriuretic effect of the organic
acid para-aminohippurate. J. Lab. Clin. Med.,
88(6), 895-903 (1976).
8. Gibbs, J. E., and Thomas, S. A., The distribution
of the anti-HIV drug, 2'3'-dideoxycytidine
and/or on the reverse side of the invoice or packing slip.
3. Soppet D., et al., Cell, 65, 895–903 (1991).
4. Meeker RB. and Williams KS., Neural Regen
Res., 10, 721-5 (2015).
5. Park H. and
distinct in vitro and in vivo
differentiation/mineralization potential. J Bone Miner Res. 14:893-903.
5. Raouf A, Seth A. (2000). Ets transcription factors and targets in osteogenesis. Oncogene.
cells in 1:10 dilution steps starting from 105 cells/ml in a multiwell culture plate (tissue-culture grade, 96- or
24-well) to approximately 1 cell per well (lowest dilution).
- We recommend 200 μl culture
distinct in vitro and in vivo
differentiation/mineralization potential. J Bone Miner Res. 14:893-903.
5. Raouf A, Seth A. (2000). Ets transcription factors and targets in osteogenesis. Oncogene.
PHENYLACETATE 98%, FCC, FG W273309 B33282 HC-22SIHH98
902. METHYL PROPIONATE W274208 C51537 HC-22SIJZ66
903. METHYL PROPYL DISULFIDE 95%, FG W320102 B41988 HC-22SICQ51
This is to certify that the following
PHENYLACETATE 98%, FCC, FG W273309 B33282 HC-22SIHH98
902. METHYL PROPIONATE W274208 C51537 HC-22SIJZ66
903. METHYL PROPYL DISULFIDE 95%, FG W320102 B41988 HC-22SICQ51
This is to certify that the following